Total Payments
$2,537
2024 Payments
$413.61
Companies
19
Transactions
199
Medicare Patients
639
Medicare Billing
$79,683
Payment Breakdown by Category
Food & Beverage$2,470 (97.3%)
Education$67.51 (2.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,470 | 195 | 97.3% |
| Education | $67.51 | 4 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. | $633.77 | 78 | $0 (2023) |
| Alkermes, Inc. | $421.28 | 27 | $0 (2023) |
| Axsome Therapeutics, Inc. | $302.57 | 14 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $224.57 | 27 | $0 (2024) |
| Corium, LLC | $154.16 | 11 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $107.44 | 6 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $96.08 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $87.04 | 5 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $84.95 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $82.82 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $413.61 | 37 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($224.57) |
| 2023 | $1,114 | 75 | ITI, Inc. ($242.14) |
| 2022 | $704.75 | 64 | ITI, Inc. ($252.54) |
| 2021 | $212.93 | 17 | ITI, Inc. ($139.09) |
| 2019 | $16.11 | 1 | Janssen Pharmaceuticals, Inc ($16.11) |
| 2018 | $60.78 | 4 | Alkermes, Inc. ($23.62) |
| 2017 | $15.08 | 1 | Sunovion Pharmaceuticals Inc. ($15.08) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: PSYCHIATRY | ||||||
| 07/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Neuropsychiatry | ||||||
| 07/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: PSYCHIATRY | ||||||
| 07/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $12.15 | General |
| Category: PSYCHIATRY | ||||||
| 06/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: PSYCHIATRY | ||||||
| 06/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: PSYCHIATRY | ||||||
| 06/24/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/16/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Neuroscience | ||||||
| 06/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: PSYCHIATRY | ||||||
| 06/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: PSYCHIATRY | ||||||
| 05/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: PSYCHIATRY | ||||||
| 05/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.36 | General |
| Category: PSYCHIATRY | ||||||
| 05/02/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 05/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 96 | 270 | $32,044 | $9,305 |
| 2022 | 5 | 281 | 759 | $72,591 | $36,781 |
| 2021 | 4 | 158 | 605 | $53,993 | $23,905 |
| 2020 | 3 | 104 | 350 | $34,618 | $9,692 |
Total Patients
639
Total Services
1,984
Medicare Billing
$79,683
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 75 | 249 | $25,452 | $7,613 | 29.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 21 | 21 | $6,592 | $1,692 | 25.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 204 | 476 | $41,888 | $15,342 | 36.6% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 14 | 96 | $11,520 | $8,971 | 77.9% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 25 | 118 | $10,620 | $7,833 | 73.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 22 | 23 | $6,263 | $3,009 | 48.0% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 16 | 46 | $2,300 | $1,627 | 70.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 87 | 350 | $30,563 | $9,561 | 31.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 33 | 149 | $13,410 | $8,788 | 65.5% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 18 | 86 | $4,300 | $3,056 | 71.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 20 | 20 | $5,720 | $2,500 | 43.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 70 | 287 | $25,080 | $5,124 | 20.4% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 16 | 44 | $3,960 | $2,631 | 66.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 18 | 19 | $5,578 | $1,936 | 34.7% |
About Dr. Dezso Halbauer, MD
Dr. Dezso Halbauer, MD is a Psychiatry healthcare provider based in Bradford, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992839625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dezso Halbauer, MD has received a total of $2,537 in payments from pharmaceutical and medical device companies, with $413.61 received in 2024. These payments were reported across 199 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,470).
As a Medicare-enrolled provider, Halbauer has provided services to 639 Medicare beneficiaries, totaling 1,984 services with total Medicare billing of $79,683. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Bradford, PA
- Active Since 03/15/2007
- Last Updated 10/28/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1992839625
Products in Payments
- CAPLYTA (Drug) $858.34
- Auvelity (Drug) $302.57
- ARISTADA (Drug) $293.22
- Azstarys (Drug) $117.55
- TRINTELLIX (Drug) $87.04
- REXULTI (Drug) $85.89
- INGREZZA (Drug) $84.95
- BELSOMRA (Drug) $82.82
- INVEGA SUSTENNA (Drug) $79.97
- QUVIVIQ (Drug) $75.26
- VIVITROL (Drug) $62.69
- PERSERIS (Drug) $50.57
- AZSTARYS (Drug) $36.61
- LATUDA (Drug) $34.96
- VRAYLAR (Drug) $29.64
- QELBREE (Drug) $27.85
- Vivitrol (Drug) $23.11
- LYBALVI (Drug) $18.64
- Austedo XR (Drug) $18.11
- NUPLAZID (Drug) $17.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.